(NCCN) Guidelines® Version 3.2022 for prostate cancer now contains a recommendation for the use of Ga-68 PSMA-11 PET / CT for bone and soft tissue imaging in prostate cancer, as an alternative to imaging.
(NCCN) Guidelines® Version 3.2022 for prostate cancer now contains a recommendation for the use of Ga-68 PSMA-11 PET / CT for bone and soft tissue imaging in prostate cancer, as an alternative to imaging.
